2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene CAS 1030825-20-7 Maʻemaʻe ≥98.0% (HPLC)

ʻO ka wehewehe pōkole:

2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene

CAS: 1030825-20-7

ʻAno: Pahu keʻokeʻo a i ʻole keʻokeʻo

Maʻemaʻe: ≥98.0% (HPLC)

ʻO waena o ka API (CAS: 842133-18-0) i ka mālama ʻana i ka Type 2 Diabetes Mellitus

Inquiry: alvin@ruifuchem.com

E hoʻouna i ka leka uila iā mākou

Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

Hāʻawi ka mea hana i nā mea waena e pili ana:
4-Fluorophenylboronic Acid CAS: 1765-93-1
2-(4-Fluorophenyl)thiophene CAS: 58861-48-6
2,3,4,6-Tetrakis-O-Trimethylsilyl-D-Gluconolactone CAS: 32384-65-9
5-Iodo-2-Methylbenzoic Acid CAS 54811-38-0
2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene CAS: 1030825-20-7
2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene CAS: 898566-17-1
CAS: 842133-18-0
CAS: 928672-86-0

Na Waiwai Kemika:

Inoa Kimia	2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene
Helu CAS	1030825-20-7
Helu CAT	RF-PI234
Kūlana Kūʻai	Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā haneli kilogram
ʻĀpana Molekala	C18H14BrFS
Kaumaha Molecular	361.27
Lae hehee	103 ℃
ʻO ka mānoanoa	1.388
Brand	ʻO Ruifu Chemical

Nā kikoʻī:

'ikamu	Nā kikoʻī
Ka nana aku	Pada keʻokeʻo a i ʻole keʻokeʻo
Maʻemaʻe / Kaʻina Hanana	≥98.0% (HPLC)
Nalo ma ka maloo	≤1.00%
Ke koena ma ka ʻā	≤0.50%
Metala Kaumaha	≤20ppm
Kūlana hoʻāʻo	ʻOihana Kūlana
Hoʻohana	Waena o API (CAS: 842133-18-0)

Pūʻolo a me ka waiho ʻana:

Pūʻolo: ʻOmole, ʻeke ʻeke Aluminum, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;Pale mai ka māmā a me ka makū

Pono:

FAQ:

Noi:

ʻO Shanghai Ruifu Chemical Co., Ltd. ka mea hana nui a me ka mea hoʻolako o 2- (5-Bromo-2-Methylbenzyl) -5- (4-Fluorophenyl) thiophene (CAS: 1030825-20-7) me ke kūlana kiʻekiʻe.ʻO iahe mea waena maʻamau i ka synthesis o API (CAS: 461432-26-8).ʻO API (CAS: 461432-26-8) he lāʻau lapaʻau antidiabetic hou i hoʻomohala ʻia e Bristol-Myers Squibb a me AstraZeneca, i ʻae ʻia e ka European Medicines Agency (EMA) ma Nowemapa 12, 2012. ʻO ia hoʻi ka mea hoʻopaneʻe SGLT2 mua no ka ka mālama ʻana i ka maʻi maʻi type II, he koho nui i ka mālama ʻana i ka maʻi diabetes, a hoʻohana ʻia e hoʻomaikaʻi i ka mana glycemic ma ke ʻano he mea hoʻohui i ka meaʻai a me ka hoʻoikaika kino no nā pākeke me ka maʻi diabetes type II.